SAB Biotherapeutics
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SAB Biotherapeutics
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.